- Login
- Register & Subscribe
- Langue: EN FR DE
Research & University News
Molecular switch for epidermal stem cells reported
Thursday 3 March 2011
Researchers at Children’s Hospital in Boston, Massachusetts have reported finding a regulator of gene activity that can instruct epidermal stem cells to grow or stop growing, a finding that may have use for cancer as well as regenerative medicine.
Location
United States
Danish group to investigate cancer pathogens
Thursday 3 March 2011
A group of Danish researchers, backed by a DKK 90 million (€12 mln) grant from the Danish National Advanced Technology Foundation, have joined forces to identify still-unknown pathogens that may cause cancer. Bavarian Nordic is a project partner.
Location
Denmark
UCB in deal with Harvard University
Thursday 3 March 2011
UCB SA of Belgium is to allocate up to $6 million over two years to a new collaboration with Harvard University focusing on research into future therapeutics for immunological diseases and diseases of the central nervous system.
Location
Belgium
Belimumab trial highlighted in The Lancet
Saturday 26 February 2011
A Phase 3 trial of the monoclonal antibody, belimumab, has shown the drug to be safe and effective for patients with systemic lupus erythematosus and may be a new option for management of the disease, according to a paper in The Lancet.
Location
United Kingdom
Scientists report discovering new oncogene
Friday 18 February 2011
Scientists based in the UK and Canada have reported identifying a new oncogene that may play a role in up to a third of the more aggressive oestrogen positive breast cancers. It is the first new breast cancer oncogene to be reported in about five years.
Location
United Kingdom
Dutch to finance study of stem cells for transplants
Friday 18 February 2011
Three Dutch organisations are allocating more than €3 million to a project that will develop a method for culturing stem cells for transplants in leukaemia patients. The study will also develop imaging technology to monitor these treatments.
Location
Netherlands
Co-development agreement for new malaria agent
Tuesday 15 February 2011
The non-profit Medicines for Malaria Venture and Jomaa Pharma GmbH of Germany have entered into an agreement to co-develop fosmidomycin as a component of a non-artemisinin based combination therapy for acute Plasmodium falciparum malaria.
Location
Germany
New findings on stem cells and hair growth
Monday 14 February 2011
Researchers from Rockefeller University in New York City have shown that stem cells that leave a special niche environment to become hair follicles send signals back to the niche in order to prevent other stem cells from activating too early.
Location
United States
Eli Lilly enlists venture capital to support virtual drug development network
Thursday 10 February 2011
Eli Lilly and Company Inc is enlisting the support of venture capitalists in the US and Europe to support its virtual drug development network that manages promising new molecules from candidate stage to clinical proof of concept.
Location
United States
PNAS reports on candidate malaria drug
Tuesday 8 February 2011
Data from a Phase 1 study of a new antimalarial drug candidate, a synthetic peroxide, have been reported in the Proceedings of the National Academy of Sciences. The compound was shown to be safe at doses of up to 1,600 mg.
Location
Switzerland
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013